Stability of extemporaneously prepared glycopyrrolate oral suspensions

被引:5
作者
Cober, Mary Petrea [1 ,2 ,3 ,4 ]
Johnson, Cary E. [3 ,4 ]
Sudekum, David
Penprase, Kimberly
机构
[1] Akron Childrens Hosp, Dept Pharm, Neonatal Intens care Unit, Akron, OH 44308 USA
[2] Northeastern Ohio Univ Coll Med & Pharm, Coll Pharm, Akron, OH USA
[3] Univ Michigan, Coll Pharm, Dept Clin Sci, Ann Arbor, MI 48109 USA
[4] UMHHC, Dept Pharm, Ann Arbor, MI USA
关键词
Chromatography; liquid; Color; Compounding; Concentration; Contamination; Glycopyrrolate; Hydrogen ion concentration; Parasympatholytic agents; Stability; Storage; Suspensions; Taste; Vehicles; SIALORRHEA;
D O I
10.2146/100247
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Purpose. The stability of extemporaneously prepared glycopyrrolate 0.5-mg/mL suspensions was evaluated. Methods. An oral suspension of glycopyrrolate 0.5 mg/mL was prepared by thoroughly grinding 30 1-mg tablets of glycopyrrolate in a glass mortar. Thirty milliliters of Ora-Plus and 30 mL of either Ora-Sweet or Ora-Sweet SF were mixed and added to the powder to make a final volume of 60 mL. Three identical samples of the formulation were prepared and placed in 2-oz amber plastic bottles with child-resistant caps and stored at room temperature (23-25 degrees C). A 1-mL sample was withdrawn from each of the three bottles with a micropipette immediately after preparation and 7, 15, 30, 60, and 90 days afterward. After further dilution to an expected concentration of 50 mu g/mL with sample diluent, the samples were assayed in duplicate by stability-indicating high-performance liquid chromatography. The samples were visually examined for any color change and evaluated for pH on each day of analysis. Taste evaluations were performed at the beginning and end of the study. Stability was defined as the retention of at least 90% of the initial concentration. Results. At least 95% of the initial glycopyrrolate remained throughout the 90-day study period in both preparations. There were no detectable changes in color, odor, taste, and pH, and no visible microbial growth was observed in any sample. Conclusion. Extemporaneously compounded suspensions of glycopyrrolate 0.5 mg/mL in a 1:1 mixture of Ora-Plus/Ora-Sweet or Ora-Plus/Ora-Sweet SF were stable for at least 90 days when stored in amber plastic bottles at room temperature.
引用
收藏
页码:843 / 845
页数:3
相关论文
共 6 条
[1]
Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy [J].
Bachrach, SJ ;
Walter, RS ;
Trzcinski, K .
CLINICAL PEDIATRICS, 1998, 37 (08) :485-490
[2]
Stability of buprenorphine, haloperidol and glycopyrrolate mixture in a 0.9 % sodium chloride solution [J].
Jäppinen, A ;
Kokki, H ;
Naaranlahti, TJ ;
Rasi, AS .
PHARMACY WORLD & SCIENCE, 1999, 21 (06) :272-274
[3]
*LEX, GLYC PED DRUG INF
[4]
Treatment of sialorrhea with glycopyrrolate - A double-blind, dose-ranging study [J].
Mier, RJ ;
Bachrach, SJ ;
Lakin, RC ;
Barker, T ;
Childs, J ;
Moran, M .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2000, 154 (12) :1214-1218
[5]
Glycopyrrolate for treatment of clozapine-induced sialorrhea in three adolescents [J].
Robb, Adelaide S. ;
Lee, Ronald H. ;
Cooper, Erin B. ;
Siedel, John V. ;
Nusrat, Nasima .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (01) :99-107
[6]
Tscheng DZ, 2002, ANN PHARMACOTHER, V36, P1785